Loading…
Femasys Inc. is projected to rise to $4.59 by 2027, a +55% move from its current price of $2.97. FEMY is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $2.78 | $2.97 | $3.18 | +0.09% |
| Aug 6 | $2.70 | $2.98 | $3.28 | +0.18% |
| Aug 7 | $2.65 | $2.98 | $3.35 | +0.27% |
| Aug 8 | $2.60 | $2.98 | $3.42 | +0.36% |
| Aug 9 | $2.56 | $2.98 | $3.47 | +0.45% |
| Aug 10 | $2.53 | $2.99 | $3.53 | +0.55% |
| Aug 11 | $2.50 | $2.99 | $3.58 | +0.64% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $2.50 | $2.99 | $3.58 | +0.64% |
| Week 2 | $2.33 | $3.01 | $3.88 | +1.28% |
| Week 3 | $2.22 | $3.03 | $4.13 | +1.92% |
| Week 4 | $2.13 | $3.05 | $4.37 | +2.57% |
| Week 5 | $2.05 | $3.07 | $4.59 | +3.23% |
| Week 6 | $1.99 | $3.09 | $4.80 | +3.88% |
| Week 7 | $1.93 | $3.10 | $5.00 | +4.54% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Femasys Inc. is a healthcare company in the biomedical field that develops and commercializes therapeutic and diagnostic products for women’s reproductive health needs in the United States and internationally.
Its product portfolio includes FemaSeed, an intratubal insemination device; FemVue, a companion diagnostic for fallopian tube assessment through ultrasound; FemSperm, a sperm handling kit; FemChec, a confirmation test for tubal patency; FemCerv, an endocervical tissue sampler for cervical cancer diagnosis; and FemCath, a cornual balloon catheter for selective tube evaluation. It also provides FemBloc, a non-surgical female permanent birth control solution. The company offers its products to gynecological physicians, related healthcare professionals, and women’s healthcare provider organizations.
Femasys Inc. was incorporated in 2004 and is headquartered in Suwanee, Georgia.
Femasys Inc. (FEMY) is currently priced at $2.78 per share and has a market capitalization of $8.39M. It is ranked 5147 by market cap.
The asset sits in the Healthcare category and presents a small-cap profile within the sector.
The year-by-year forecast suggests upside potential over the next years: in 2026 the min is $2.78, the avg is $2.78, and the max is $4.46 with a 0% ROI and neutral sentiment; rising thereafter toward 2027–2050 with higher avg values and meaningful ROIs, culminating at an avg price of $9.67 by 2050 with a 247.9% ROI. The trajectory indicates bullish sentiment starting in 2027 and extending through 2050.
A major floor 88.7% below — a decisive break under it would weaken the trend.
The nearest floor, 6.4% below — buyers have tended to step in here.
The nearest ceiling, 46.5% above — a clean break opens room to run.
A major ceiling 105.3% above — clearing it would confirm fresh momentum.
Key FEMY support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of FEMY market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.91 | Buy | $2.98 | Sell |
| MA 10 | $3.27 | Sell | $3.16 | Sell |
| MA 20 | $3.46 | Sell | $3.32 | Sell |
| MA 50 | $3.11 | Sell | $2.96 | Buy |
| MA 100 | $1.78 | Buy | $2.25 | Buy |
| MA 200 | $1.23 | Buy | $1.63 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 42.89 | Neutral |
| Stoch RSI (14) | 9.59 | Buy |
| CCI (20) | -104.76 | Sell |
| Williams %R (14) | -92.92 | Info |
| MACD (12,26,9) | -0.13 | Sell |
| ROC (12) | -19.89 | Sell |
| Bollinger %B (20,2) | 0.15 | Neutral |
| Stochastic %K (14) | 7.08 | Buy |
| TRIX (15) | 0.07 | Buy |
| Awesome (5,34) | -0.77 | Sell |
| Ultimate (7,14,28) | 33.16 | Neutral |
| Momentum (10) | -0.15 | Sell |
| Aroon Osc (25) | -76.00 | Sell |
| Hull MA (9) | 2.64 | Buy |
| ADX (14) | 15.24 | Neutral |
| ATR (14) | 0.24 | Info |
The 30-day technical picture is NEUTRAL. The RSI14 is 30, and the near-term momentum is subdued.
Key moving averages show the landscape: SMA50 at $4.86 and SMA200 at $10.32. The price is currently supported at $2.78 and faces resistance around $4.35. The 30-day price range spans from $1.73 to $4.46, highlighting a tight but volatile window in the near term.
Annualized volatility is 100%, underscoring the elevated risk/return profile typical of small-cap healthcare names.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.78 | $2.97 | $4.66 | 0% | Neutral | |
| $3.35 | $4.59 | $6.81 | +55% | Bullish | |
| $3.47 | $5.07 | $8.02 | +71% | Bullish | |
| $3.09 | $4.75 | $7.89 | +60% | Bullish | |
| $3.14 | $5.06 | $8.76 | +70% | Bullish | |
| $2.44 | $4.11 | $7.37 | +38% | Bullish | |
| $2.13 | $3.74 | $6.91 | +26% | Bullish | |
| $3.03 | $5.54 | $10.54 | +87% | Bullish | |
| $3.23 | $6.16 | $12.01 | +107% | Bullish | |
| $3.24 | $6.43 | $12.82 | +116% | Bullish | |
| $3.37 | $7.48 | $16.41 | +152% | Bullish | |
| $4.57 | $10.16 | $23.37 | +242% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $2.78 | $2.97 | $3.64 | +0.00% |
| September 2026 | $2.65 | $3.22 | $4.09 | +8.51% |
| October 2026 | $2.62 | $3.23 | $4.17 | +0.10% |
| November 2026 | $2.53 | $3.16 | $4.16 | -2.05% |
| December 2026 | $2.77 | $3.49 | $4.66 | +10.56% |
Click any year to see its month-by-month FEMY forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, FEMY is projected to trade between $2.78 and $4.66, averaging $2.97 — a potential gain of 0% from today's $2.97. Price action looks broadly range-bound.
Femasys Inc.'s 2027 outlook centres on $4.59, within a $3.35 to $6.81 range. That is up +55% on the projected 2026 average. That marks a +55% change versus current levels. Buyers look set to stay in control over this stretch.
By 2028, FEMY could reach as high as $8.02, with a base case around $5.07 and support toward $3.47 — roughly +71% from $2.97. Momentum favours further upside here.
Expect FEMY to range from $3.09 to $7.89 through 2029. The $4.75 average target implies a +60% move from current prices. That is -6% versus the projected 2028 average. Buyers look set to stay in control over this stretch.
The FEMY price prediction for 2030 points to an average of $5.06 (low $3.14, high $8.76) — a potential gain of +70% on today's $2.97. Momentum favours further upside here.
In 2031, FEMY is projected to trade between $2.44 and $7.37, averaging $4.11 — a potential gain of +38% from today's $2.97. That is -19% versus the projected 2030 average. Buyers look set to stay in control over this stretch.
Femasys Inc.'s 2032 outlook centres on $3.74, within a $2.13 to $6.91 range. That is -9% versus the projected 2031 average. That marks a +26% change versus current levels. Momentum favours further upside here.
By 2033, FEMY could reach as high as $10.54, with a base case around $5.54 and support toward $3.03 — roughly +87% from $2.97. Buyers look set to stay in control over this stretch.
Expect FEMY to range from $3.23 to $12.01 through 2034. The $6.16 average target implies a +107% move from current prices. That is up +11% on the projected 2033 average. Momentum favours further upside here.
The FEMY price prediction for 2035 points to an average of $6.43 (low $3.24, high $12.82) — a potential gain of +116% on today's $2.97. Buyers look set to stay in control over this stretch.
In 2040, FEMY is projected to trade between $3.37 and $16.41, averaging $7.48 — a potential gain of +152% from today's $2.97. That is up +16% on the projected 2035 average. Momentum favours further upside here.
Femasys Inc.'s 2050 outlook centres on $10.16, within a $4.57 to $23.37 range. That is up +36% on the projected 2040 average. That marks a +242% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in FEMY today (≈ 336.700337 FEMY) could be worth
$3,421.77
+$2,421.77 (+242%) by 2050 · US Dollar
Based on the average projected FEMY price of $10.16 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in FEMYwould be worth at today's price.
$1,000 invested in FEMY on Jul 31, 2025 (≈ 1,206.272623 FEMY) would be worth
$3,582.63
+$2,582.63 (+258.3%) today · 3.58× · US Dollar
Based on a FEMY entry price of $0.829 vs. today's $2.97.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $3.71 | $800.54 | -19.9% |
| 1 month ago | $4.35 | $682.76 | -31.7% |
| 3 months ago | $0.384 | $7,734.37 | +673.4% |
| 6 months ago | $0.516 | $5,755.81 | +475.6% |
| 1 year ago | $0.829 | $3,582.63 | +258.3% |
| All time (5.0y) ago | $7.24 | $410.22 | -59.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our FEMY forecast.
Our base-case forecast reaches $5.90 around 2034.
Implied market cap at $5.90: $17.82M
The multi-year forecast points to a bullish arc across the 2027–2050 horizon, with the average price steadily rising from the 2026 baseline toward significantly higher levels. In 2030, the avg price is projected at $4.69 with a max of $8.13 and a min of $2.91, yielding a 68.8% ROI in a bullish context. By 2040, the avg price is $7.00 with a max of $15.35 and a min of $3.15, delivering a 151.8% ROI.
By 2050, the avg price is forecast at $9.67 with a max of $22.25 and a min of $4.35, for a 247.9% ROI. Across these years, sentiment shifts to BULLISH in successive periods, reflecting expected upside despite inherent uncertainty.
These are estimates, not guarantees, and actual results may differ due to factors not captured in the forecast. Investors should consider the range of outcomes and the inherent risk in small-cap healthcare equities when evaluating such projections.
Tap a question to reveal the answer.
2030 min $2.91, avg $4.69, max $8.13 with ROI 68.8% and sentiment BULLISH.
Forecasts show neutral in 2026, then bullish from 2027 onward, with 2027 avg $4.26, 2028 avg $4.74, 2029 avg $4.51, 2030 avg $4.69, 2040 avg $7.00, and 2050 avg $9.67 with ROIs of 53.2%, 70.5%, 62.1%, 68.8%, 151.8%, and 247.9% respectively.
Yes. The max forecast reaches $11.28 in 2034, with $9.86 as the 2033 max, implying a path above $10 within the forecast window.
The current price is $2.78.
2026 min $2.78, avg $2.78, max $4.46 with ROI 0 and sentiment NEUTRAL.
Femasys Inc. Community Discussion
0Share your Femasys Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.